A recent analysis by the European Animal Research Association underscores NHPs’ pivotal contribution to neuroscience, infectious disease research, and vaccine development, particularly in modeling human-like immune and neurological responses. But with tighter regulations, shrinking colonies, and growing activism calling for alternatives, global academic researchers and pharmaceuticals are facing a tough question: How to access high-quality NHP biospecimens—legally, ethically, and scientifically? That’s where Creative Biolabs is making waves.
Beyond Samples: A Precision Research Ecosystem
With the biomedical world clamoring for access to NHP cerebrospinal fluid (CSF), peripheral blood mononuclear cells (PBMCs), serum, tissues, and more, Creative Biolabs, leveraging 15+ years in biomaterials and reagents, has transformed NHP sourcing from commodity to scientific partnership with:
- Superior Inventory: Verified monkey CSF samples with matched PBMC/tissues—the golden standard for neuroscience studies.
- Zero Wild-Caught Policy: All animals from authority-accredited facilities with lifetime health dossiers. All specimens come with detailed metadata, including genotype information, collection timelines, donor health records, and experimental context.
- Disease Modeling Co-Development: Collaborate on custom disease model development, allowing clients to co-engineer research pipelines aligned with their therapeutic targets.
“It’s not just a sample—it’s a scientific story ready to be told,” said a scientist of NHP platforms at Creative Biolabs. “What sets us apart is the traceability and transparency.”
The platform supports an extensive suite of NHP biospecimens, with particularly strong capabilities in CSF collection. For instance, the African green monkey CSF samples are gaining traction among biotechnology enterprises due to their relevance in neuroinflammation studies.
Connect at 2025’s Premier CNS & Biotherapeutics Summits
See how ethical sourcing accelerates discovery at Creative Biolabs’ Q3 showcases:
- Oligonucleotides for CNS Summit (Aug 27-29, Boston)
- World Bispecific Summit (Sep 9-11, Boston)
- Exosome Therapeutic Summit (Sep 23-25, San Diego)
The Ethical Edge
“Sustainability isn’t optional—it’s scientifically necessary,” the scientist emphasizes. “That’s why we’ve adhered to rigorous science without compromising ethics.”
About Creative Biolabs
Serving 10,000+ clients in 50+ countries. ISO 9001 certified. All procedures adhere to animal welfare standards. Not for human use.
About the Author
Creative Biolabs supports laboratory NHP preclinical studies with a wide array of biological products, including whole blood, serum, plasma, primary cells, tissue, body fluids, and recombinant reagents. As a specialized contract research organization, we offer diverse NHP disease models, providing biologicals from diseased primates. Recognizing the complexity and sensitivity of NHPs in biomedical research, we have developed specialized infrastructure and care to maintain their well-being. Despite the controversy surrounding NHP use, we ensure a steady supply and high-quality service to meet the urgent needs of biomedical research through our dedicated monitoring and evaluation platform.
